TIGIT and neoplasm: Although the mice treated with VV-α-TIGIT only showed a trend of lower tumor volume compare to mice treated with VV-Control (P > 0.05) (Fig. 5F), these mice demonstrated a significantly longer survival time than mice treated with VV-Control (P <0.01) (Fig. 5G).